» Articles » PMID: 33901223

Self-collected and Clinician-collected Anal Swabs Show Modest Agreement for HPV Genotyping

Overview
Journal PLoS One
Date 2021 Apr 26
PMID 33901223
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aim: Women with HIV/HPV coinfection and cervical lesions are at increased risk of developing HPV related anal cancer. Self-collection of anal swabs may facilitate HPV molecular testing in anal cancer screening, especially in high-risk groups, and yet it is not adequately studied. We evaluated level of agreement between self-collected anal swabs (SCAS) and clinician-collected anal swabs (CCAS) when used for HPV genotyping. We also described the anal HPV genotype distribution and HIV/HPV coinfection.

Methods: We performed a cross sectional study with participants from a visual-inspection-with-acetic-acid and cervicography (VIAC) clinic, in Harare, Zimbabwe. In a clinic setting, the women aged ≥18 years provided anal swabs in duplicate; first CCAS and then SCAS immediately after. HPV detection and genotyping were performed using next generation amplicon sequencing of a 450bp region of the HPV L1 gene. Level of agreement of HPV genotypes between CCAS and SCAS was calculated using the kappa statistic. McNemar tests were used to evaluate agreement in the proportion of genotypes detected by either method.

Results: Three-hundred women provided 600 samples for HPV genotyping. HPV genotypes were detected in 25% of SCAS and in 22% of CCAS. The most common genotypes with CCAS were HPV52, HPV62 and HPV70 and with SCAS were HPV62, HPV44, HPV52, HPV53 and HPV68. Total HPV genotypes detected in CCAS were more than those detected in SCAS, 32 versus 27. The agreement of HPV genotypes between the two methods was 0.55 in kappa value (k). The test of proportions using McNemar gave a Chi-square value of 0.75 (p = 0.39). Multiple HPV infections were detected in 28/75 and 29/67 women for CCAS and SCAS respectively.

Conclusions: SCAS and CCAS anal swabs showed moderate agreement, with no statistically significant difference in the proportion of genotypes detected by either methods. Although the differences between the two methods were not statistically significant, CCAS detected more HPV genotypes than SCAS and more HPV infections were detected in SCAS than in CCAS. Our data suggest that self-collected anal swabs can be used as an alternative to clinician-collected anal swabs for HPV genotyping.

Citing Articles

Self- versus clinician-collected swabs in anal cancer screening: A clinical trial.

Dyer C, Jin F, Roberts J, Poynten I, Farnsworth A, McNally L PLoS One. 2025; 20(1):e0312781.

PMID: 39787107 PMC: 11717180. DOI: 10.1371/journal.pone.0312781.


Changes in microbial composition and interaction patterns of female urogenital tract and rectum in response to HPV infection.

Dong Y, Luo Y, Liu C, Huang W, Feng L, Zou X J Transl Med. 2024; 22(1):125.

PMID: 38303030 PMC: 10832222. DOI: 10.1186/s12967-024-04916-2.


Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practice.

Spindler L, Etienney I, Abramowitz L, de Parades V, Pigot F, Siproudhis L Tech Coloproctol. 2024; 28(1):23.

PMID: 38198036 PMC: 10781838. DOI: 10.1007/s10151-023-02899-8.


Variability of High-Risk Human Papillomavirus and Associated Factors among Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.

Tchouaket M, Kae A, Ngoufack Jagni Semengue E, Sosso S, Kamgaing Simo R, Yagai B Pathogens. 2023; 12(8).

PMID: 37623992 PMC: 10458438. DOI: 10.3390/pathogens12081032.


Correction: Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping.

Mandishora R, Rounge T, Fitzpatrick M, Christiansen I, Ambur O, Lagstrom S PLoS One. 2023; 18(7):e0288418.

PMID: 37418482 PMC: 10328305. DOI: 10.1371/journal.pone.0288418.


References
1.
Cranston R, Darragh T, Holly E, Jay N, Berry J, Da Costa M . Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men. J Acquir Immune Defic Syndr. 2004; 36(4):915-20. DOI: 10.1097/00126334-200408010-00004. View

2.
Palefsky J, Holly E, Ralston M, Da Costa M , Greenblatt R . Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis. 2001; 183(3):383-91. DOI: 10.1086/318071. View

3.
Palefsky J . Human papillomavirus-associated anal and cervical cancers in HIV-infected individuals: incidence and prevention in the antiretroviral therapy era. Curr Opin HIV AIDS. 2016; 12(1):26-30. PMC: 5292043. DOI: 10.1097/COH.0000000000000336. View

4.
Lampinen T, Miller M, Chan K, Anema A, van Niekerk D, Schilder A . Randomized clinical evaluation of self-screening for anal cancer precursors in men who have sex with men. Cytojournal. 2006; 3:4. PMC: 1435770. DOI: 10.1186/1742-6413-3-4. View

5.
Wayal S, Llewellyn C, Smith H, Hankins M, Phillips A, Richardson D . Self-sampling for oropharyngeal and rectal specimens to screen for sexually transmitted infections: acceptability among men who have sex with men. Sex Transm Infect. 2008; 85(1):60-4. DOI: 10.1136/sti.2008.032193. View